Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAX Trial
NL-OMON21156Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in polyneuropathy and Neuralgia comparing Lacosamide with Duloxetine (2 arms). Primary endpoint: Pain relief. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
lacosamideduloxetine
03
Conditions
polyneuropathyNeuralgia
Beyond the preview
Go deeper on NL-OMON21156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21156.